Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine–PNA (peptide nucleic acid) conjugates

By Shiraishi Takehiko   Nielsen Peter E.  

Nucleic Acids Research, Vol. 32, Iss. 16, 2004-01 ,pp. : 4893-4902

Oxford University Press

Access to resources Recommend Favorite

Improved cell-penetrating peptide–PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle

By Ivanova Gabriela D.  

Nucleic Acids Research, Vol. 36, Iss. 20, 2008-11 ,pp. : 6418-6428

Oxford University Press

Access to resources Recommend Favorite

Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells

By Turner John J.   Ivanova Gabriela D.   Verbeure Birgit   Williams Donna   Arzumanov Andrey A.   Abes Saïd   Lebleu Bernard   Gait Michael J.  

Nucleic Acids Research, Vol. 33, Iss. 21, 2005-01 ,pp. : 6837-6849

Oxford University Press

Access to resources Recommend Favorite

A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro‐inverso delivery peptide. The antisense activity depressesthe target mRNA and protein in magnocellularoxytocin neurons

By Aldrian‐Herrada Gudrun   Desarménien Michel G.   Orcel Hélène   Boissin‐Agasse Line   Méry Jean   Brugidou Jean   Rabié Alain  

Nucleic Acids Research, Vol. 26, Iss. 21, 1998-11 ,pp. : 4910-4916

Oxford University Press

Access to resources Recommend Favorite

Imaging gene expression in the brain with peptide nucleic acid (PNA) antisense radiopharmaceuticals and drug targeting technology

By Ruben J. Boado  

Letters in Peptide Science, Vol. 10, Iss. 3-4, 2003-01 ,pp. : 169-190

Springer Publishing Company

Access to resources Recommend Favorite